Cidara Therapeutics (CDTX) Priced

Preclinical biotech developing novel therapies for fungal infections.

Health Care - Biotechnology

IPO Performance
Latest Trade $11.70 0.00 (0.0%)
First Day Return 0.0%
Return from IPO -26.9%
 
Cidara Therapeutics IPO News more
  • .
IPO Data
IPO File Date 03/13/2015
Offer Price $16.00
Price Range $14.00 - $16.00
Offer Shares (mm) 4.8
Deal Size ($mm) 77
 
IPO Data
IPO Date 04/14/2015
Offer Price $16.00
Price Range $14.00 - $16.00
Offer Shares (mm) 4.8
Deal Size ($mm) $77
 
Underwriters
more
Business Overview
Preclinical biotech developing novel therapies for fungal infections.
Preclinical biotech developing novel therapies for fungal infections.
more
Company Data
Headquarters San Diego, CA
Founded 2012
Employees 33
Website www.cidara.com
 

Performance vs. IPO Index (IPOUSA)